Quadrivalent combined vaccine, including diphtheria toxoid, tetanus toxiod, detoxified whole cell pertussis, and Hepatitis B surface antigen

Journal of Microbiology and Biotechnology

Volumn 13, Issue 3, 2003, Pages 338-343

  Cheon Soon, Bae ^a   Lim, Gwan Yeul ^a   Kim, Jong Su ^a   Hur, Byung Ki ^b  

^a Green Cross Company   (South Korea)

^b Inha University   (South Korea)

Author keywords

Combined vaccine; Immunogenicity; Separately simultaneous administration

Indexed keywords

ALUMINUM HYDROXIDE; DIPHTHERIA TOXOID; HEPATITIS B SURFACE ANTIGEN; HEPAVAX; PERTUSSIS VACCINE; TETANUS TOXOID;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG DOSE; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG POTENCY; DRUG SYNTHESIS; GEL; IMMUNOGENICITY; MOUSE; NONHUMAN; PERTUSSIS; PH;

ANIMALIA;

EID: 0037898537     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bae, C. S., K. N. Park, S. J. Ahn, J. S. Kim, and B. K. Hur. 2002. Novel formulation of quadrivalent combined vaccine including diphtheria toxoid, tetanus toxoid, acellular pertussis antigens and hepatitis B surface antigen. J. Microbiol. Biotechnol. 12: 787-792.
2. Cooper, P. D. 1994. The selective induction of different immune responses by vaccine adjuvants, pp. 125-158. In Ada, G. L. (ed.), Strategies in Vaccine Design, Landes Company, Austin, U.S.A.
3. Gupta, R. K. and B. E. Rost. 2000. Aluminum compounds its vaccine adjuvants, pp. 73-74. In O'Hagan, D. T. (ed.), Vaccine Adjuvants: Preparation Methods and Research Protocols. Humana Press, New Jersey, U.S.A.
4. Gupta, R. K., B. E. Rost, E. Relyveld, and G. R. Siber. 1995. Adjuvant properties of aluminum and calcium compounds, pp. 229-248. In Powell, M. F. and M. J. Newman (eds.), Vaccine Design: The Subunit and Adjuvant Approach, Plenum Publishing Corporation, New York, U.S.A.
5. Gupta, R. K. and G. R. Siber. 1995. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13: 1263-1276.
6. 3 as an immunological adjuvant. Acta Pathol. Microbiol. Immun. Scand. 96: 257-264.
7. Park, J. H., E. W. Cho, D. G. Lee, J. M. Park, Y. J. Lee, E. A. Choi, and K. L. Kim. 2000. Receptor-mediated endocytosis of Hepatitis B virus preS1 protein in EBV-transformed B-cell line. J. Microbiol. Biotechnol. 10: 844-850.
8. Shirodkar, S., R. L. Hutchinson, D. L. Perry, J. L. White, and S. L. Hem. 1990. Aluminum compounds used as adjuvants in vaccines. Pharmaceut. Res. 7: 1282-1288.
9. Yasuo, M. and T. Atsuko. 1996. Hepatitis B vaccine, pp. 171-180. In Akira, O. (ed.), Vaccine Handbook, The National Institute of Health, Tokyo, Japan.
10. Yuji, S. and S. Hiroko. 1996. Diphtheria, tetanus, and pertussis (DTP) combined vaccine, pp. 68-71. In Akira, O. (ed.), Vaccine Handbook, The National Institute of Health, Tokyo, Japan.